![Gordon Ngan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gordon Ngan
Profile
Gordon Ngan worked as an Executive Director-Corporate Development at Cytochroma, Inc., a Principal at Shire Plc, a Research Analyst at Canaccord Adams, and an Associate at National Bank Financial, Inc. (Broker).
He also worked as a Principal at Biochem Pharma, Inc. Mr. Ngan holds an MBA from Queen's University and an undergraduate degree from the University of Toronto.
Former positions of Gordon Ngan
Companies | Position | End |
---|---|---|
Shire Plc /Old/
![]() Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Corporate Officer/Principal | - |
Biochem Pharma, Inc.
![]() Biochem Pharma, Inc. Pharmaceuticals: OtherHealth Technology Biochem Pharma, Inc. provides bioinfomatics tools, biotechnology databases and consulting services to the genomics, proteomics and biopharmaceutical industries. They provide the cutting edge strategic intelligence needed to exploit information and to develop future business strategies. | Corporate Officer/Principal | - |
National Bank Financial, Inc. (Broker)
![]() National Bank Financial, Inc. (Broker) Investment Banks/BrokersFinance National Bank Financial, Inc. (Broker) (NBF-Broker) is the broker/dealer division of National Bank Financial, Inc., a Canadian mutual fund manager headquartered in Montréal, Quebec. The firm was founded in 1902 and is a direct subsidiary of National Bank Acquisition Holding, Inc., ultimately owned by National Bank of Canada (TSX: NA). NBF-Broker provides retail advisory and brokerage services with institutional brokerage, investment banking, corporate finance and securities clearing services for third parties. The firm has a substantial presence in all regions of Canada, as well as operations in the US and Europe. | Analyst-Equity | - |
Cytochroma, Inc.
![]() Cytochroma, Inc. Pharmaceuticals: MajorHealth Technology Cytochroma, Inc. is a clinical-stage specialty pharmaceutical company. It develops and markets prescription products for the prevention of vitamin D insufficiency. The firm specializes in pharmaceutical products to treat and prevent secondary hyperparathyroidism associated with chronic kidney disease. The company was founded by Martin J. Petkovich in 1996 and is headquartered in Markham, Canada. | Corporate Officer/Principal | - |
Canaccord Adams
![]() Canaccord Adams Investment Banks/BrokersFinance Canaccord Adams is an independent financial services firm and broker/dealer headquartered in Vancouver, British Columbia with additional offices in Calgary, Montreal, Toronto and Halifax. The firm's analysts search worldwide for emerging and small- to mid-cap growth opportunities, identifying value and exposing risk. The research team analyzes seven sectors, clarifying current events and anticipating market trends in high-quality daily, weekly and monthly research products. Canaccord Adams focuses on the following sectors: metals and mining, energy, technology, life sciences, real estate and gaming, consumer and industrial growth. The firm is a subsidiary of Canaccord Financial, Inc. | Analyst-Equity | - |
Training of Gordon Ngan
Queen's University | Masters Business Admin |
University of Toronto | Undergraduate Degree |
Experiences
Positions held
Linked companies
Private companies | 5 |
---|---|
Canaccord Adams
![]() Canaccord Adams Investment Banks/BrokersFinance Canaccord Adams is an independent financial services firm and broker/dealer headquartered in Vancouver, British Columbia with additional offices in Calgary, Montreal, Toronto and Halifax. The firm's analysts search worldwide for emerging and small- to mid-cap growth opportunities, identifying value and exposing risk. The research team analyzes seven sectors, clarifying current events and anticipating market trends in high-quality daily, weekly and monthly research products. Canaccord Adams focuses on the following sectors: metals and mining, energy, technology, life sciences, real estate and gaming, consumer and industrial growth. The firm is a subsidiary of Canaccord Financial, Inc. | Finance |
National Bank Financial, Inc. (Broker)
![]() National Bank Financial, Inc. (Broker) Investment Banks/BrokersFinance National Bank Financial, Inc. (Broker) (NBF-Broker) is the broker/dealer division of National Bank Financial, Inc., a Canadian mutual fund manager headquartered in Montréal, Quebec. The firm was founded in 1902 and is a direct subsidiary of National Bank Acquisition Holding, Inc., ultimately owned by National Bank of Canada (TSX: NA). NBF-Broker provides retail advisory and brokerage services with institutional brokerage, investment banking, corporate finance and securities clearing services for third parties. The firm has a substantial presence in all regions of Canada, as well as operations in the US and Europe. | Finance |
Cytochroma, Inc.
![]() Cytochroma, Inc. Pharmaceuticals: MajorHealth Technology Cytochroma, Inc. is a clinical-stage specialty pharmaceutical company. It develops and markets prescription products for the prevention of vitamin D insufficiency. The firm specializes in pharmaceutical products to treat and prevent secondary hyperparathyroidism associated with chronic kidney disease. The company was founded by Martin J. Petkovich in 1996 and is headquartered in Markham, Canada. | Health Technology |
Biochem Pharma, Inc.
![]() Biochem Pharma, Inc. Pharmaceuticals: OtherHealth Technology Biochem Pharma, Inc. provides bioinfomatics tools, biotechnology databases and consulting services to the genomics, proteomics and biopharmaceutical industries. They provide the cutting edge strategic intelligence needed to exploit information and to develop future business strategies. | Health Technology |
Shire Plc /Old/
![]() Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Commercial Services |
- Stock Market
- Insiders
- Gordon Ngan